Terns Pharmaceuticals, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Terns Pharmaceuticals, Inc.
CIK #0001831363
EDGAR Form CIK 2011 - 2026
10-K [0001831363]
10-Q [0001831363]
3 [0001831363]
4 [0001831363]
8-K [0001831363]
D [0001831363]
SC 13D [0001831363]
SC 13G [0001831363]
Form 13D/13G Filer Form 13D/13G Subject Filed
Adage Capital Management LP Terns Pharmaceuticals Inc [2026-02-12]
Vanguard Group Inc Terns Pharmaceuticals Inc [2025-10-31]
Morgan Stanley Terns Pharmaceuticals Inc [2025-05-07]
BlackRock Inc Terns Pharmaceuticals Inc [2024-11-08]
BlackRock Inc Terns Pharmaceuticals Inc [2024-10-24]
Citadel Advisors LLC Terns Pharmaceuticals Inc [2024-07-22]
Soleus Capital Master Fund LP Terns Pharmaceuticals Inc [2024-06-07]
Point72 Asset Management LP Terns Pharmaceuticals Inc [2024-03-07]
BlackRock Inc Terns Pharmaceuticals Inc [2024-01-31]
Integrated Core Strategies US LLC Terns Pharmaceuticals Inc [2024-01-25]
View All
Form 3/4/5 Subject 2011 - 2026
Kindler Jeffrey B
Terns Pharmaceuticals, Inc.
Gengos Andrew
Turner Heather D
Kuriakose Emil
Fellows David A
Azelby Robert
Tripuraneni Radhika
Quigley Jill M.
Burroughs Amy L.
View All
Terms | Privacy | Guide
tony@aum13f.com